Simpson Millar LLP Solicitors in Birmingham, Bristol, Cardiff, Gateshead, Lancaster, Leeds, London, Manchester, Sheffield & Wimbledon
RSS Feed image Follow Simpson_millar on Twitter image Follow us on LinkedIn image Find us on Facebook image   Simpson Millar on Google+  See this page in PolishPolish

Over-prescription of anti-anxiety drugs heralding increase in medical negligence claims
Dated: 12/04/2012  Key Contact: Neil Fearn   

Prescription DrugsUse of benzodiazepine drugs with adverse effects over the long term is creating circumstances whereby more claims for medical negligence could be made against over-prescription.

Benzodiazepine (known colloquially as 'benzo' and abbreviated as 'BZD') is a family of psychoactive drugs. Used in the body its variants enhance the effect of the neurotransmitter gamma-aminobutyric acid (GABA), thus acting as a sedative, an anti-convulsant and a muscle relaxant with anti-anxiety properties.

Such properties make benzodiazepine helpful in treating anxiety, insomnia, agitation, seizures, muscle spasms, alcohol withdrawal and as pre-medication for surgical procedures.

The benzodiazepine family includes such variants as temazepam (which has become the UK's most frequently abused prescription drug); diazepam (better known as Valium) and clonazepam, which is widely prescribed to people with spinal injury in order to ease neurological pain and spasms.

While cognitive impairments and paradoxical effects such as aggression are sometimes reported, benzodiazepines are considered generally safe and effective when used in the short term.

Over longer periods, however, persistent use of benzodiazepines has led to concerns about adverse psychological and physical effects, raising the spectre of more claims for medical negligence against physicians who over-prescribe the drugs.

Users of clonazepam, for example, have found the drug helpful in fighting spasms which would otherwise keep them constantly awake at night. It quickly reduces anxiety, quells panic symptoms and enables its users to drift swiftly into sleep.

However, any drug which works straight away is also likely to be highly addictive. It is estimated that as many as 33% of people who use clonazepam for longer than 4 weeks can develop a dependence.

Withdrawal symptoms experienced under such circumstances include anxiety, aggressiveness, irritability and even hallucinations and episodes of psychosis.

Older people run an increased risk of suffering from both short- and long-term adverse effects. There is also particular controversy surrounding pregnant women's safety when using benzodiazepines, which may have caused babies to be born with cleft palates and even withdrawal symptoms of their own.

Overdosing on benzodiazepines can lead to dangerously deep unconsciousness. Although they are less toxic than barbiturates, their clinical predecessors, and death rarely occurs when a benzodiazepine is taken alone, the potential for toxicity rises when the drug is combined with other central nervous system depressants such as alcohol and opiates.

Given the known facts, it is clearly wise to be absolutely certain that any symptoms you might be experiencing, from spinal cord injury to anxiety, genuinely warrant the use of benzodiazepine variants. Failing this, medical negligence claims against over-subscription can only increase.

Useful Links



Get the news direct to your Email Inbox


If you liked this article you can sign up to receive our news articles via email here: Subscribe to our Daily News updates


PR Contact


For any PR enquiries please contact:


Christina Savage at RTS Media on tel: 01942 396701, mobile: 07932 944 008 or send an email.


Disclaimer: No information on this website shall be construed as legal advice and information is offered for general information purposes only based on the current law when the information was first displayed on this website. You should always seek advice from an appropriately qualified solicitor on any specific legal enquiry. Calls to or from our legal helpline may be recorded for training and monitoring purposes.

External links are provided for your convenience, but they are beyond the control of Simpson Millar LLP and no representation is made as to their content. Use or reliance on any external links and the content thereon provided is at your own risk. Full terms of use...


All copyright in this website and in any materials appearing on this website: © Simpson Millar 2008. Simpson Millar LLP solicitors is a limited liability partnership registered in England and Wales with registered number OC313936. Our registered office is: 27 St Paul's Street, Leeds LS1 2JG. Vat number: 235 9349 40.

Simpson Millar LLP has offices in Birmingham, Bristol, Cardiff, Gateshead, Lancaster, Leeds, London, Manchester, Sheffield and Wimbledon.

If you experience any problems when using this website please email: webmaster@simpsonmillar.co.uk.

Authorised and Regulated by the Solicitors Regulation Authority: Registration No: 424940 Regulatory Information

Investors in People, Lexcel, Law Society Personal Injury, Family Law, Medical Negligence Panels and Best Companies, SIA Spinal Injury Association gold sponsor logo images Law Society Personal Injury Panel Law Society Clinical Negligence Panel Law Society Family Law Panel Investors in People Lexcel Best Companies Guide - One to Watch Spinal Injuries Association - Gold corporate sponsor